Table 2 Proportion of correct responses to knowledge exam questions pre- and post-module completion (n = 65)
Topic Assesseda | Pre-module n (%) | Post-module n (%) | p-value | |
|---|---|---|---|---|
1. Cancer screening (general principles) | 52 (80.0%) | 60 (92.3%) | 0.027 | |
2. Puberty blocking therapy (clinical considerations) | 63 (96.9%) | 62 (95.4%) | 1.00 | |
3. Puberty blocking therapy (eligibility criteria) | 40 (61.5%) | 46 (70.8%) | 0.264 | |
4. Feminizing hormone therapy | 24 (36.9%) | 42 (64.6%) | 0.004 | |
5. Masculinizing hormone therapy | 4 (6.2%) | 39 (60.0%) | < 0.001 | |
6. Breast cancer screening | 37 (56.9%) | 48 (73.8%) | 0.010 | |
7. Health insurance | 38 (58.5%) | 46 (70.8%) | 0.136 | |
8. Informed consent | 30 (46.2%) | 50 (76.9%) | 0.001 | |
9. Gender affirming surgery | 46 (70.8%) | 59 (90.8%) | 0.004 | |
10. Fertility | 20 (30.8%) | 46 (70.8%) | < 0.001 | |
Scaled score (out of 15) Mean (SD) | 9.65 (1.81) | 12.5 (2.20) | < 0.001 | |